Kaya, G. Et Al. 2022. Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients? . Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain , (Barcelona, Spain), 71-72.

Kaya, G., Volkan Salancı, B., Aydın, G. B., & Özgen Kıratlı, M. P., (2022). Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients? . Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain (pp.71-72). Barcelona, Spain

Kaya, GÜRSAN Et Al. "Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients? ," Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain, Barcelona, Spain, 2022

Kaya, GÜRSAN Et Al. "Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients? ." Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain , Barcelona, Spain, pp.71-72, 2022

Kaya, G. Et Al. (2022) . "Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients? ." Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain , Barcelona, Spain, pp.71-72.

@conferencepaper{conferencepaper, author={GÜRSAN KAYA Et Al. }, title={Are Interim TLG and MTV Better Predictors of Treatment Than Deaville Score for Pediatric Non-Hodgkin Lymphoma Patients? }, congress name={Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain}, city={Barcelona}, country={Spain}, year={2022}, pages={71-72} }